-+ 0.00%
-+ 0.00%
-+ 0.00%

Coya Therapeutics amends filing to name Mark Pavao to audit committee

PUBT·08/07/2026 21:03:48
Listen to the news
Coya Therapeutics amends filing to name Mark Pavao to audit committee
  • Coya Therapeutics filed an amended Form 8-K to update board committee assignments disclosed in its March 29, 2026 report.
  • Mark H. Pavao was appointed to the board’s Audit Committee on Aug. 6, 2026, effective immediately.
  • The Audit Committee now includes Dov Goldstein as chair, Ann Lee, Dieter Weinand, Mark H. Pavao.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340449), on August 07, 2026, and is solely responsible for the information contained therein.